Two cases of uneventful pregnancies following the treatment of choriocarcinoma
暂无分享,去创建一个
[1] R. Berkowitz,et al. Diagnosis and management of gestational trophoblastic disease: 2021 update , 2021, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[2] S. Sun,et al. Gestational trophoblastic neoplasia: Novelties and challenges. , 2021, Placenta.
[3] M. Seckl,et al. Fertility and pregnancy outcome in gestational trophoblastic disease , 2021, International Journal of Gynecological Cancer.
[4] Junjun Yang,et al. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥ 5 , 2021 .
[5] M. Seckl,et al. Treatment of gestational trophoblastic disease in the 2020s. , 2020, Current opinion in obstetrics & gynecology.
[6] J. Tidy,et al. Placental site trophoblastic tumour and epithelioid trophoblastic tumour. , 2020, Best practice & research. Clinical obstetrics & gynaecology.
[7] H. Ngan,et al. Surgery including fertility-sparing treatment of GTD , 2020, Best Practice & Research Clinical Obstetrics & Gynaecology.
[8] M. Seckl,et al. Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease. , 2020, European journal of cancer.
[9] D. Maucort-Boulch,et al. Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapy. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] M. De Felici,et al. Ovarian damage from chemotherapy and current approaches to its protection , 2019, Human reproduction update.
[11] N. Sebire,et al. When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients. , 2019, Gynecologic oncology.
[12] H. Wand,et al. Reproductive outcomes following treatment for a gynecological cancer diagnosis: a systematic review , 2019, Journal of Cancer Survivorship.
[13] A. Gadducci,et al. Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group , 2017, International Journal of Gynecologic Cancer.
[14] A. Iwase,et al. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia. , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[15] N. Tanaka,et al. Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor. , 2003, Gynecologic oncology.